Tabcorp – FY18 Earnings Upgrade

Tabcorp (TAH.ASX) will likely see $20m+ in earnings upgrade from the NSW Government’s decision to reverse its ban on greyhound racing from FY18.

FY17 revenue of $2.3b looks flat on the same time last year, with EBIT of $350m and EPS $0.23. Out into FY18 the investment case picks up. FY18 revenue $2.35b, EBIT jumps to $370m on $0.25 of EPS and a forward yield of 5%+. With a  relatively high payout ratio and 20x PE, the stock looks slightly expensive and we prefer to be a buyer on a dip back below $5.00

TAH.ASX

tah

CWN.ASX

Crown looks attractive at or near $13.00 with gaming revenue picking up in Macau and the pending breakup of the ASX listed Crown business splitting into 3 separate entities, unlocking value for shareholders.

cwn

 

 

 

 

CIMIC Takeover Offer for UGL

CIMIC (CIM.ASX) announced it intends to make a takeover offer for UGL at $3.15 per share. This is almost a 50% premium to UGL’s last traded price and values the business at $520m.

Pre UGL, FY17 EPS growth in CIM is forecast to increase by 5% to approximately $1.90, assuming they payout around $1.10 in dividends,  it places the stock on a forward yield of 4%, (100% franking credit).

It’s worth adding CIM.ASX to your watch list as the UGL acquisition will help strengthen the investment case.

CIM.ASX

cim

UGL.ASX

ugl

 

 

 

Global Macro

In the lead up to last Friday’s US Payroll (NFP) report, there were several Federal Reserve officials, as well as many market commentators, who believed that a better-than-expected jobs report would increase the likelihood of  a November rate hike. Even FED “dove “Charles Evans seemed to warm to the idea that above trend growth in employment would justify a near-term move in the Fed Funds target.

However, the less than spectacular Non-Farm Payroll report saw the odds of a November move scaled back materially, the USD lose some of its gains for the week.

We have never  really supported the speculation about further rate normalization at the November FOMC meeting. There is no historic precedent for any FED policy change so close to a Federal election and the current FED will likely want to show a political and independent posture.

In addition, the November FOMC doesn’t have a scheduled press conference nor are any updated economic forecasts scheduled for release. These scheduling issues wouldn’t completely preclude a rate hike if the recent data was extremely strong; which is not the case. On balance, the NFP report was solid even though the headline new jobs component was weaker-than-expected. Private sector jobs gained 167,000, while the participation rate rose to 63% which is the best rate since February of 2014.

Chart – US 10yr

10yr

Dow Jones

dow-jones

 

BOQ FY16 Earnings Result

A quick look at Bank of Queensland and Bendigo following the release of the BOQ FY16 earnings result.  BOQ.ASX Underlying result was weaker than market expectations, predominately driven by greater than expected margin pressure.

BOQ.ASX FY17 outlook now appears to offer flat EPS growth at best, assuming a $0.78 FY17 dividend, it places the stock on a 6.9% fully franked forward yield.

BOQ.ASX

boq

BEN.ASX

ben

A technical summary of where we see price action heading is different in BOQ opposed to BEN, whilst we see short term downside pressure in both names, (despite the yield support), a retracement in BEN.ASX back to $10 will likely trigger a buy signal in our algorithm engines. Whereas, BOQ.ASX remains in a structural downtrend and it’s the current short signal that draws our attention.

 

 

 

 

Resmed 1QFY17 – Get Ready to Buy

Resmed (RMD.ASX) reports first quarter FY17 results on the 26th of October. The result is likely to meet or exceed market expectations.

RMD is forecast to deliver 10%+ in EPS growth across the next few years. The recent acquisition of Brightree, Inova and Curative Medical will underpin both revenue and future profit growth, within an industry sector where demand continues to grow.

rmd

 

Caltex Continues to Perform

We hold Caltex (CTX.ASX) across most client portfolios from lower price levels. The algorithm engines triggered the entry signal back on 8th of July when CTX.ASX was trading at $32.00.

Our target was $34+ with a view towards selling covered calls at this point to then achieve an average exit price in the range of $36 to $37 or on a stand still basis, (or unexercised), 10% per annum cash flow from the dividend and option premium.

The investment continues to perform as expected.

FY17 forecast EPS of $2.15 with a forward yield of 3.3%. Underlying growth 5 – 7%.

Chart – CTX.ASX

ctx

 

 

Global Macro

Over the past 12 months, the correlation between the EURO and Eurozone (EZ) share market has gone through several different phases. Earlier in the year, the single currency was sold off on risk aversion when EZ equities were showing weakness. A few months later, the EURO was bid higher when EZ stocks fell as fund managers allegedly unwound currency hedges while cutting long stock positions.

However, during last Friday’s LDN session, the EUR/USD tracked the German DAX index with pretty much a point-to-point correlation. As discussed in previous FX UPDATES, the legal and financial pressures on Deutsche Bank (DB), along with other EZ banks, has been a headwind for the EURO but so far hasn’t unravelled the current price or chart structure.

But last Friday was different. As the LDN session opened, the German DAX was pushed below the 10,200 level for the first time since early August. At the same time, the EUR/USD fell to the session low of 1.1160 and was well offered on the crosses. A well timed rumor that the US Department of Justice  (DoJ) was willing to lower their penalty demand on DB down to the $5.0 billion area triggered a 1.5% rally in the DAX and reversed the EUR/USD back up to near-term resistance at 1.1250.

With a full slate of data points from both sides of the Atlantic this week, FX Investors will be watching to see if this EURO-Equity connection of stronger EZ equities driving the EUR/USD higher has any staying power, or if it was just an end of month adjustment.

It’s our base case is that the DoJ rumor was just that and the market will be sensitive to ongoing litigation between the DB and the DoJ. Further, two of the key data points this week, US ISM aggregates and the US Jobs data, are both extremely currency sensitive releases which will drive USD flows.

On balance, we expect both the ISM manufacturing and services reports to bounce back from last month’s readings, which would be USD positive and SP 500 positive. The US Payroll data has been a volatile series over the last six months, but a print near the forecasted number of 170,000 new jobs should be good enough to keep the EUR/USD on a downward trajectory.

Chart – Deutsche Bank

dbank

 

Take Profit on Boral and Buy James Hardie

In today’s post we look at stocks recently commented on that require further attention, as profit taking is in sight or the entry level setups are now looking compelling.

NVT.ASX – Lift trailing stop loss to $5.25 support and retain profit target at $5.40

nvt

BLD.ASX – We had a buy recommendation on this at $6.20 and it has now rallied 10%+ to $6.85. Take profit on BLD and switch to JHX.

bld

AMC.ASX – We see value in AMC at $15 only when complemented with a covered call strategy. Target is 7% capital growth, plus 2% from Feb div and 3% option premium. We have a six month time horizon on this trade.

amc

ASX.ASX – Looks better value following the recent pullback and our algorithm engines are flagging a buy point.

asx

The above charts summarise a few opportunities we’re watching. For further detail on our investment ideas, visit the monthly strategy piece or the recent mid week update.

If you have trouble locating the links to either of the above recordings, please email me.

leon@investorsignals.com

 

 

 

 

 

 

Global Macro

Today’s NY close will mark both the end of September and the end of the third quarter of 2016. Often times, these month-end, quarter-end trading sessions can see broad reversion moves within long worn price ranges. With the UK current account data scheduled for release today, could month-end flows lift the Sterling into the weekend?

Doing a straight quarter-to-quarter price analysis, the GBP/USD looks overdue for a substantial recovery. The pair started Q2 of 2016 at 1.4250 and started Q3 more than 10 big figures lower at 1.3225. Over the last couple of months, the GBP/USD has been trading in an inverse pennant formation bound by the 1.2850 level on the downside and finding resistance just under 1.3500.

During the same period, the FTSE 100 has gained just over 4%, which illustrates a combination of over expectations of widespread asset devaluation post-Brexit and the re-pricing of growth assets relative to the lower Sterling.

The UK balance of payment report is first-tier data set and has been heavily influenced by the sharp devaluation of the Sterling since the June 24th referendum. Market forecasts are calling for a contraction of the trade deficit from – £32.00 billion to -£30.00 billion. And while seeing the deficit shrink by 2 billion quid may not appear to be a large improvement, it’s still materially better than blowout numbers predicted by Brexit opponents.

Chart – FTSE

ftseEUR/USD

eurusd